From the ranks of mammary progesterone mediators, RANKL takes the spotlight
- 21 September 2011
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 357 (1-2), 91-100
- https://doi.org/10.1016/j.mce.2011.09.030
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior HysterectomyJAMA, 2011
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerNature, 2010
- The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouseDevelopmental Biology, 2009
- Challenges to defining a role for progesterone in breast cancerSteroids, 2007
- Regulation of cancer cell migration and bone metastasis by RANKLNature, 2006
- Generation of a functional mammary gland from a single stem cellNature, 2006
- Purification and unique properties of mammary epithelial stem cellsNature, 2006
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896